Background: The prevalence of excess weight has increased globally. Despite interventions include targeted goals on essential aspects such as physical activity and diet, their long-term effectiveness remains limited. Research highlights that eating behaviour is influenced by impulsive processes, especially in the context of a food-rich environment. Inhibitory control has been identified as a key factor in regulating eating behaviour. Neuroscience approaches, including inhibitory control training and non-invasive neuromodulation of brain regions such as the dorsolateral prefrontal cortex, show promise in improving eating behaviour when used in addition to conventional intervention for weight management. This parallel group, randomized, controlled trial aims to study the efficacy of neuromodulation with iTBS as an add-on to the weight loss treatment as usual (TAU: diet and exercise), alone and in combination with inhibitory control training, for excess weight treatment.
Methods And Analysis: 141 people with excess weight will be randomized into three groups: combined intervention (inhibitory control training + iTBS), iTBS and sham iTBS. The three groups will receive individualized diet and physical exercise guidelines (TAU). The interventions will comprehend ten sessions along two weeks. The main outcome measure will be the Body Mass Index change. Secondary outcomes include changes in brain connectivity and activation using fMRI, cognitive measures, eating and physical exercise behaviours, anthropometric and biological measures. Assessments will be carried out before the intervention, after the intervention and 3 months after the intervention. In addition, data on the use of the health system will be collected to analyse the cost-effectiveness and the cost-utility of the intervention.
Discussion: Findings of this study will expand the available evidence on cognitive interventions to improve eating behaviour in people with excess weight.
Trial Registration: The trial has been registered at www.
Clinicaltrials: gov under the number NCT06668077 on the 11th of February 2025 named Inhibitory Control Training and iTBS for Excess Weight Behavioral and Brain Changes (InhibE). Any relevant modification to the protocol will be reflected in the clinical trial registry in www.
Clinicaltrials: gov.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1186/s40359-025-02556-9 | DOI Listing |
Cancer Med
March 2025
Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Background: Tumor metastasis is one of the main causes of death in cancer patients; however, the mechanism controlling metastasis is unclear. The posttranscriptional regulation of metastasis-related genes mediated by AT-rich interactive domain-containing protein 4A (Arid4a), an RNA-binding protein (RBP), has not been elucidated.
Methods: Bioinformatic analysis, qRT-PCR, immunohistochemistry, and immunoblotting were employed to determine the expression of Arid4a in breast tumor tissues and its association with the survival of cancer patients.
Clin Exp Dent Res
February 2025
Clinical Sciences Department, College of Dentistry, Ajman University, Ajman, United Arab Emirates.
Objective: This systematic review aimed to evaluate the current evidence regarding the impact of postbiotics on dental caries, focusing on the effectiveness of postbiotic interventions in caries prevention, mechanisms of action, optimal dosages, and administration protocols.
Methods: A literature search was conducted across PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included randomized controlled trials, quasi-experimental, observational, and in vitro studies.
Neurogastroenterol Motil
March 2025
Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P. R. China.
Backgrounds And Aims: Achalasia is an acquired esophageal neurodegenerative disorder, characterized by selective loss of inhibitory neurons in the myenteric plexus of the lower esophageal sphincter (LES). The Enteric neural precursor cell (ENPC) is essential in maintaining neurogenesis, but its role in achalasia pathogenesis is unknown. This study aimed to explore the neurogenesis status in the LES among achalasia patients.
View Article and Find Full Text PDFIran J Pharm Res
January 2025
Department of Biology, Kazeroon Branch, Islamic Azad University, Kazeroon, Iran.
Background: Obesity, a rising global health issue, is linked to numerous disorders, including cognitive impairment.
Objectives: This study investigates the effects of coenzyme Q10 (Co-Q10) on cognitive performance, antioxidant defense, cholinergic activity, and hippocampal neuron damage in rats rendered obese by monosodium glutamate (MSG) exposure.
Methods: Forty-eight neonatal male Wistar rats were randomly assigned to one of four groups: Control, MSG, MSG + Q10-10, and MSG + Q10-20.
Heliyon
February 2025
São Paulo State University (UNESP), School of Dentistry, Araraquara, SP, Brazil.
The growing global threat posed by microorganisms resistant to conventional antimicrobials underscores the urgent need for novel agents to control infections. The aim of this study was to evaluate the antimicrobial activity and biocompatibility of alpha-silver tungstate (α-AgWO) nanoparticles (NPs) synthesized by the ultrasonic method. The NPs were characterized, and their antimicrobial activity was assessed against , , and using the broth microdilution method, determining the minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!